发明申请
US20140349997A1 HYDROXYLATED AND METHOXYLATED PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS
有权
羟基和甲氧基吡咯烷酮作为AKT蛋白激酶抑制剂
- 专利标题： HYDROXYLATED AND METHOXYLATED PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS
- 专利标题（中）： 羟基和甲氧基吡咯烷酮作为AKT蛋白激酶抑制剂
-
申请号： US14458062申请日： 2014-08-12
-
公开(公告)号： US20140349997A1公开(公告)日： 2014-11-27
- 发明人: Ian S. Mitchell , James F. Blake , Rui Xu , Nicholas C. Kallan , Dengming Xiao , Keith Lee Spencer , Josef R. Bencsik , Eli M. Wallace , Stephen T. Schlacter , Anna L. Banka , Jun Liang , Brian Safina , Birong Zhang , Christine Chabot , Steven Do
- 申请人： Array BioPharma Inc. , Genentech, Inc.
- 主分类号： C07D413/12
- IPC分类号： C07D413/12 ; C07D401/12 ; C07D409/14 ; C07D407/12 ; C07D409/12 ; C07D239/70 ; C07D403/12
摘要：
The present invention provides compounds, including resolved enantiomers, resolved diastereomers, solvates and pharmaceutically acceptable salts thereof, comprising the Formula I: Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.
公开/授权文献
信息查询
